Literature DB >> 28074065

HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia.

P Mehdipour1, F Santoro1, O A Botrugno2, M Romanenghi1, C Pagliuca1, G M Matthews3, R W Johnstone4,5, S Minucci1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28074065     DOI： 10.1038/leu.2017.3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.

Authors:  Raffaella Villa; Lluis Morey; Veronica A Raker; Marcus Buschbeck; Arantxa Gutierrez; Francesca De Santis; Massimo Corsaro; Florencio Varas; Daniela Bossi; Saverio Minucci; Pier Giuseppe Pelicci; Luciano Di Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner.

Authors:  Melissa Malvaez; Susan C McQuown; George A Rogge; Mariam Astarabadi; Vincent Jacques; Samantha Carreiro; James R Rusche; Marcelo A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

3.  A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.

Authors:  Fabio Santoro; Oronza A Botrugno; Roberto Dal Zuffo; Isabella Pallavicini; Geoffrey M Matthews; Leonie Cluse; Iros Barozzi; Silvia Senese; Lorenzo Fornasari; Simona Moretti; Lucia Altucci; Pier Giuseppe Pelicci; Susanna Chiocca; Ricky W Johnstone; Saverio Minucci
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

4.  PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.

Authors:  John S Welch; Wenlin Yuan; Timothy J Ley
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

5.  Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.

Authors:  Marinus R Heideman; Roel H Wilting; Eva Yanover; Arno Velds; Johann de Jong; Ron M Kerkhoven; Heinz Jacobs; Lodewyk F Wessels; Jan-Hermen Dannenberg
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

Review 6.  The role of histone deacetylases (HDACs) in human cancer.

Authors:  Santiago Ropero; Manel Esteller
Journal:  Mol Oncol       Date:  2007-03-07       Impact factor: 6.603

7.  High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.

Authors:  Peter Westervelt; Andrew A Lane; Jessica L Pollock; Kristie Oldfather; Matthew S Holt; Drazen B Zimonjic; Nicholas C Popescu; John F DiPersio; Timothy J Ley
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

Review 8.  Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.

Authors:  M R Corces-Zimmerman; R Majeti
Journal:  Leukemia       Date:  2014-07-09       Impact factor: 11.528

9.  Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.

Authors:  Geoffrey M Matthews; Parinaz Mehdipour; Leonie A Cluse; Katrina J Falkenberg; Eric Wang; Mareike Roth; Fabio Santoro; Eva Vidacs; Kym Stanley; Colin M House; James R Rusche; Christopher R Vakoc; Johannes Zuber; Saverio Minucci; Ricky W Johnstone
Journal:  Blood       Date:  2015-10-07       Impact factor: 22.113

10.  Target engagement and drug residence time can be observed in living cells with BRET.

Authors:  Matthew B Robers; Melanie L Dart; Carolyn C Woodroofe; Chad A Zimprich; Thomas A Kirkland; Thomas Machleidt; Kevin R Kupcho; Sergiy Levin; James R Hartnett; Kristopher Zimmerman; Andrew L Niles; Rachel Friedman Ohana; Danette L Daniels; Michael Slater; Monika G Wood; Mei Cong; Yi-Qiang Cheng; Keith V Wood
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919
View more
  1 in total

1.  Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.

Authors:  Xiaoyang Li; Yuqi Jiang; Yuri K Peterson; Tongqiang Xu; Richard A Himes; Xin Luo; Guilin Yin; Elizabeth S Inks; Nathan Dolloff; Stephanie Halene; Sherine S L Chan; C James Chou
Journal:  J Med Chem       Date:  2020-05-06       Impact factor: 7.446
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.